3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
14
Paclitaxel
13
Carboplatin
12
Bevacizumab
7
Specimen Handling
6
Cisplatin
6
olaparib
5
Taxes
5
Fulvestrant
5
Nivolumab
4
Megestrol Acetate
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
palbociclib
3
durvalumab
3
Oxaliplatin
3
Leucovorin
3
Letrozole
3
Immunoglobulin G
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
Disulfides
3
trastuzumab deruxtecan
2
ribociclib
2
pertuzumab
2
lenvatinib
2
ipatasertib
2
dostarlimab
2
capivasertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Immune Checkpoint Inhibitors
×
30 days
×
Clear all
No trials found.